Jove
Visualize
Contact Us

Related Experiment Videos

The endocannabinoid system.

Steven T Boyd1

  • 1Xavier University, Natchitoches, Louisiana 71457, USA.

Pharmacotherapy
|November 28, 2006
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system, involving cannabinoid-1 receptors, is linked to obesity and cardiometabolic risk. This system influences fat accumulation and food intake, impacting health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin pump therapy training and management: an opportunity for community pharmacists.

Journal of managed care pharmacy : JMCP·2008
Same author

Improvement in psoriasis following treatment with gabapentin and pregabalin.

American journal of clinical dermatology·2008
Same author

Taranabant, a novel cannabinoid type 1 receptor inverse agonist.

Current opinion in investigational drugs (London, England : 2000)·2008
Same author

Medication therapy management survey of the prescription drug plans.

Journal of the American Pharmacists Association : JAPhA·2006
Same author

Outcomes of pharmacist-managed diabetes care services in a community health center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2006
Same author

Exercise for low-income patients with diabetes: a continuous quality improvement project.

The Diabetes educator·2006
Same journal

Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Physiology
  • Endocrinology
  • Metabolism

Background:

  • The endocannabinoid system (ECS) plays a crucial role in regulating various physiological processes.
  • Cannabinoid-1 receptors (CB1Rs) are widely distributed and implicated in metabolic disorders.
  • Adipose tissue is now recognized as an active endocrine organ releasing adipokines.

Purpose of the Study:

  • To explore the link between the endocannabinoid system and obesity.
  • To understand the role of adipose tissue in cardiometabolic risk.
  • To investigate the influence of ECS activity on metabolic health.

Main Methods:

  • Review of current literature on the endocannabinoid system.
  • Analysis of studies investigating cannabinoid-1 receptor distribution and function.

Related Experiment Videos

  • Examination of research on adipose tissue endocrine functions and adipokines.

    • Main Results:

    • Cannabinoid-1 receptors are present throughout the body and associated with obesity and cardiometabolic risk.
    • Elevated ECS activity correlates with increased food intake and fat accumulation.
    • Adipokines released by adipose tissue significantly influence cardiometabolic risk factors.

    Conclusions:

    • The endocannabinoid system is a key regulator of energy balance and metabolic health.
    • Dysregulation of the ECS contributes to obesity and associated cardiometabolic complications.
    • Targeting the ECS may offer therapeutic strategies for metabolic diseases.